grant

Attentional Mechanisms of Cognitive Compensation in Subjective Cognitive Decline and AD Risk

Organization VANDERBILT UNIVERSITY MEDICAL CENTERLocation NASHVILLE, UNITED STATESPosted 15 Sept 2023Deadline 31 May 2028
NIHUS FederalResearch GrantFY2025A β-42A β42A-beta 42A-beta42AD dementiaAD modelAD pathologyAbeta-42Abeta42Academic Medical CentersAddressAffectAgingAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer risk factorAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimer's disease modelAlzheimer's disease pathologyAlzheimer's disease riskAlzheimer's pathologyAlzheimers DementiaAmyloid beta-42Amyloid beta42Amyloid β-42Amyloid β42Amyloidβ-42Amyloidβ42Anti-CholinergicsAnticholinergic AgentsAnticholinergicsAttentionAβ-42Aβ42Behavioral SciencesBrainBrain Nervous SystemCareer Development AwardsCareer Development Awards and ProgramsCareer Development Programs K-SeriesClinicalClinical ResearchClinical StudyClinical TreatmentClinical TrialsCognitionCognition DisordersCognitiveCognitive DisturbanceCognitive ImpairmentCognitive agingCognitive declineCognitive function abnormalCollaborationsCompensationComplementComplement ProteinsDeteriorationDevelopmentDiseaseDisease ProgressionDisorderDisturbance in cognitionDoctor of PhilosophyDrugsEEGElectroencephalogramElectroencephalographyEncephalonEnvironmentExperimental ModelsFailureFunctional MRIFunctional Magnetic Resonance ImagingFundingFutureGoalsHumanImpaired cognitionImpairmentIndividualInterventionIntervention StudiesInvestigatorsK-AwardsK-Series Research Career ProgramsLeadershipMT-bound tauMaintenanceMeasuresMedialMedicationMedicineMemoryMentorsModern ManNerve Transmitter SubstancesNeurobiologyNeurosciencesNeurotransmittersPathologicPathologyPerformancePh.D.PhDPharmaceutical AgentPharmaceutical PreparationsPharmaceuticalsPharmacologic SubstancePharmacological SubstancePlacebosPrimary Senile Degenerative DementiaProcessPsyche structurePsychiatryR-Series Research ProjectsR01 MechanismR01 ProgramResearchResearch Career ProgramResearch GrantsResearch PersonnelResearch Project GrantsResearch ProjectsResearch ProposalsResearch ResourcesResearchersResourcesRoleSeveritiesSham TreatmentSystemTauopathiesTestingTherapeuticTrainingTranslatingUniversity Medical CentersWorkaged brainaging brainalzheimer modelalzheimer riskamyloid pathologybasal forebraincareercareer developmentcholinergicclinical diagnosisclinical interventionclinical therapycognitive assessmentcognitive changecognitive diseasecognitive disordercognitive dysfunctioncognitive enhancementcognitive functioncognitive losscognitive neurosciencecognitive performancecognitive processcognitive syndromecognitive testingcomplementationdevelopmentaldrug/agentexperiencefMRIfMRI/EEGfunctional magnetic resonance imaging/electroencephalographyimprovedintervention researchinterventional researchinterventional studyinterventions researchmedial temporal areamedial temporal lobementalmesial temporal areamesial temporal lobemicrotubule bound taumicrotubule-bound tauneural imagingneuro-imagingneurobiologicalneurobiological mechanismneuroimagingneurological imagingneuropathologicneuropathologic tauneuropathologicalneuropathological tauneuropathologyolder adultolder adulthoodpharmaceuticalpre-clinicalpreclinicalpreservationprimary degenerative dementiaprofessorresearch studysenile dementia of the Alzheimer typesham therapysocial roletautau Proteinstau associated neurodegenerationtau associated neurodegenerative processtau driven neurodegenerationtau factortau induced degenerationtau induced neurodegenerationtau mediated neurodegenerationtau neurodegenerative diseasetau neuropathologytau pathologytau pathophysiologytau proteinopathytau related neurodegenerationtau-induced pathologytauopathic neurodegenerative disordertauopathytemporal measurementtemporal resolutiontime measurementtrial regimentrial treatmentτ Proteins
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Attentional Mechanisms of Cognitive Compensation in Subjective Cognitive Decline and AD Risk
Candidate: Dr. Kimberly Albert, PhD is an assistant professor in the Department of Psychiatry and Behavioral
Sciences at the Vanderbilt University Medical Center with a strong background in cognitive and systems
neuroscience. Her long-term career goals…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →

Explore more

📍 More grants in UNITED STATES🏷 More NIH opportunities🏷 More US Federal opportunities🏷 More Research Grant opportunities🏢 All nih_reporter opportunities
Attentional Mechanisms of Cognitive Compensation in Subjective Cognitive Decline and AD Risk — VANDERBILT UNIVERSITY MED | Dev Procure